- Home
- AIXI vs IMCC Comparison
AIXI vs IMCC Comparison
Compare AIXI & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIXI | IMCC |
|---|---|---|
| Founded | 2001 | 1980 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 10.4M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIXI | IMCC |
|---|---|---|
| Price | $0.65 | $1.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 189.8K | 124.9K |
| Earning Date | 12-26-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $70,314,315.00 | $37,606,703.00 |
| Revenue This Year | $26.84 | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.84 | 1.92 |
| 52 Week Low | $0.60 | $0.93 |
| 52 Week High | $6.65 | $7.12 |
Technical Indicators
Market Signals| Indicator | AIXI | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 48.13 |
| Support Level | $0.64 | $1.65 |
| Resistance Level | $0.71 | $1.84 |
| Average True Range (ATR) | 0.08 | 0.19 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 19.98 | 61.63 |
Price Performance
Historical ComparisonAbout AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.